IFP Advisors’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.7K | Buy |
733
+682
| +1,337% | +$6.58K | ﹤0.01% | 3358 |
|
|
2026
Q1 | $378 | Buy |
51
+13
| +34% | +$137 | ﹤0.01% | 4488 |
|
|
2025
Q4 | $447 | Buy |
+38
| New | +$410 | ﹤0.01% | 4309 |
|
|
2025
Q3 | – | Sell |
-199
| Closed | -$1.45K | – | 4900 |
|
|
2025
Q2 | $1.45K | Buy |
199
+190
| +2,111% | +$1.53K | ﹤0.01% | 4039 |
|
|
2025
Q1 | $85 | Hold |
9
| – | – | ﹤0.01% | 3896 |
|
|
2024
Q4 | $148 | Buy |
+9
| New | +$140 | ﹤0.01% | 3875 |
|
|
2023
Q1 | – | Sell |
-9
| Closed | -$5K | – | 4060 |
|
|
2022
Q4 | $5K | Buy |
+9
| New | +$84 | ﹤0.01% | 3795 |
|
|
2022
Q1 | – | Sell |
-236
| Closed | -$8K | – | 4580 |
|
|
2021
Q4 | $8K | Buy |
236
+36
| +18% | +$1.41K | ﹤0.01% | 2311 |
|
|
2021
Q3 | $10K | Sell |
200
-108
| -35% | -$5K | ﹤0.01% | 2283 |
|
|
2021
Q2 | $14K | Sell |
308
-2,861
| -90% | -$127K | ﹤0.01% | 2085 |
|
|
2021
Q1 | $153K | Hold |
3,169
| – | – | ﹤0.01% | 963 |
|
|
2020
Q4 | $170K | Buy |
3,169
+2,382
| +303% | +$108K | 0.01% | 879 |
|
|
2020
Q3 | $28K | Buy |
787
+87
| +12% | +$3.23K | ﹤0.01% | 1504 |
|
|
2020
Q2 | $21K | Hold |
700
| – | – | ﹤0.01% | 1551 |
|
|
2020
Q1 | $19K | Buy |
700
+500
| +250% | +$15K | ﹤0.01% | 1507 |
|
|
2019
Q4 | $6K | Hold |
200
| – | – | ﹤0.01% | 2125 |
|
|
2019
Q3 | $4K | Buy |
+200
| New | +$4.69K | ﹤0.01% | 2443 |
|
|
2019
Q1 | – | Sell |
-19
| Closed | – | – | 3037 |
|
|
2018
Q4 | $0 | Hold |
19
| – | – | ﹤0.01% | 3748 |
|
|
2018
Q3 | $0 | Buy |
+19
| New | +$263 | ﹤0.01% | 3946 |
|
|
2017
Q4 | – | Sell |
-3,000
| Closed | -$33K | – | 4002 |
|
|
2017
Q3 | $33K | Hold |
3,000
| – | – | ﹤0.01% | 2267 |
|
|
2017
Q2 | $27K | Hold |
3,000
| – | – | ﹤0.01% | 2398 |
|
|
2017
Q1 | $24K | Hold |
3,000
| – | – | ﹤0.01% | 2380 |
|
|
2016
Q4 | $26K | Sell |
3,000
-1,500
| -33% | -$12.8K | ﹤0.01% | 2287 |
|
|
2016
Q3 | $37K | Sell |
4,500
-1,000
| -18% | -$8.39K | ﹤0.01% | 2002 |
|
|
2016
Q2 | $44K | Buy |
+5,500
| New | +$44.1K | ﹤0.01% | 1849 |
|
|
2016
Q1 | – | Sell |
-3,000
| Closed | -$24K | – | 3033 |
|
|
2015
Q4 | $24K | Buy |
+3,000
| New | +$22K | ﹤0.01% | 2057 |
|
Other funds holding NEO
FLAM
GF
NAMI
B
IFP Advisors's NEO Position: Q2 2026 in Review
IFP Advisors increased its NeoGenomics (NEO) stake by 1,337% in Q2 2026, buying an estimated $6.58K and bringing the position to 733 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3358.
IFP Advisors first reported a position in NEO in Q4 2015 and has held it in 26 quarters since. The position peaked at $170K in Q4 2020. 266 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- IFP Advisors held 733 shares of NeoGenomics worth $10.7K as of Q2 2026.
- IFP Advisors bought 682 NeoGenomics shares in Q2 2026, an estimated $6.58K.
- NeoGenomics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #3358 holding.
- IFP Advisors first reported a position in NeoGenomics in Q4 2015 and has held it in 26 quarters since.
- IFP Advisors's NeoGenomics position peaked at $170K in Q4 2020.
- 266 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.